CReATe Fertility Centre, Toronto, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada.
IVF Unit, Department of Obstetrics & Gynecology, Shamir Medical Center, Zerifin, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Reprod Biomed Online. 2021 Apr;42(4):849-858. doi: 10.1016/j.rbmo.2021.01.007. Epub 2021 Jan 19.
What are the views and emotional reactions of patients towards the suspension of fertility treatment during the COVID-19 pandemic, and what are the factors affecting their psychological distress?
A cross-sectional study conducted in an academic fertility centre. Online questionnaires were distributed between 18 April 2020 and 23 April 2020 to patients whose treatment cycle had been postponed or discontinued. The outcome measures included agreement with the reproductive society guidelines to postpone treatments; willingness to resume treatments, given the choice; patients' emotional reactions; and psychological distress level, measured by the Mental Health Inventory validated scale. A multivariate linear regression was conducted to identify factors associated with psychological distress.
Because of the small number of male respondents, only women were included in the analysis (n = 181). Forty-three per cent expressed disagreement with the guidelines and 82% were willing to resume treatments, given the choice. Sadness and anxiety were the most common emotional reactions expressed towards the guidelines. In the multivariate analysis, COVID-19-related anxiety (B = 0.145, P = 0.04) and disagreement with treatment suspension (B = -0.44, P = 0.001) were found to be significantly associated with patients' psychological distress. Background characteristics of patients did not contribute significantly to their distress.
Suspension of fertility treatment during the initial phase of the COVID-19 pandemic was associated with patients' negative emotional reactions. Anxiety related to COVID-19 and disagreement with treatment suspension were found to be significantly associated with psychological distress among women undergoing fertility treatment, regardless of their background characteristics. Our findings suggest the need to monitor the mental health of patients and provide psychological support should a shutdown of fertility care re-occur.
在 COVID-19 大流行期间,患者对暂停生育治疗的看法和情绪反应是什么,哪些因素会影响他们的心理困扰?
这是一项在学术生育中心进行的横断面研究。于 2020 年 4 月 18 日至 23 日期间向治疗周期被推迟或中断的患者在线分发问卷。主要结局指标包括:同意生殖协会关于推迟治疗的指南;如果有选择,是否愿意恢复治疗;患者的情绪反应;以及使用经过验证的心理健康量表测量的心理困扰程度。进行了多变量线性回归分析,以确定与心理困扰相关的因素。
由于男性受访者人数较少,因此仅对女性(n=181)进行了分析。43%的人不同意该指南,82%的人如果有选择,愿意恢复治疗。对该指南表达的最常见情绪反应是悲伤和焦虑。在多变量分析中,发现与 COVID-19 相关的焦虑(B=0.145,P=0.04)和对治疗暂停的不同意(B=-0.44,P=0.001)与患者的心理困扰显著相关。患者的背景特征对其困扰没有显著贡献。
在 COVID-19 大流行的初期暂停生育治疗与患者的负面情绪反应有关。与 COVID-19 相关的焦虑和对治疗暂停的不同意与接受生育治疗的女性的心理困扰显著相关,而与患者的背景特征无关。我们的研究结果表明,有必要监测患者的心理健康,并在生育保健再次关闭时提供心理支持。